Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Adamis Pharmaceuticals Corp

+ Add to Watchlist

ADMP:US

0.7000 USD 0.0200 2.94%

As of 20:10:00 ET on 05/24/2013.

Company Profile for Adamis Pharmaceuticals Corp (ADMP)

Adamis Pharmaceuticals Corp. is a specialty pharmaceuticals company. The Company is focused on developing new treatment for viral infections, including influenza. Adamis markets and sells a line of prescription products for a variety of allergy, respiratory disease and pediatric conditions.

Contact Information

Adamis Pharmaceuticals Corp

2658 Del Mar Heights Rd
#555
Del Mar, CA 19512
United States
Phone: 1-858-401-3984

Key Executives for Adamis Pharmaceuticals Corp (ADMP)

Dennis J CarloPresident/CEODavid J MarguglioSenior VP:Corporate Dev
Robert O HopkinsVP:Finance/CFOKaren K DanielsVP:Operations
Thomas MollVP:Research

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil